drugset / Trial / NCT01688401

Intra-arterial Chemotherapy for the Treatment of Progressive Diffuse Intrinsic Pontine Gliomas (DIPG).

NCT01688401

NaSingle-groupOpen-labelOther

Summary

The goal of this pilot study is to determine if intra-arterial (IA) chemotherapy is safe in the treatment of progressive diffuse intrinsic pontine gliomas (DIPG). IA administration of the chemotherapeutic agent enhances the regional distribution of the drug, thereby increasing the local delivered dose while minimizing systemic toxicity. It also provides a treatment option for these patients at the time of tumor recurrence.

Timeline

Start
2013-03-08
Primary completion
2017-05
Completion
2018-11-26

Drugs

EvaluationDrugModalityDoseRoute
Subject Melphalan Small molecule 2 mg Other